NEOsphere Biotechnologies
Exhibitor
NEOsphere Biotechnologies is a biotechnology company focused on accelerating induced proximity drug discovery through high-throughput proteomics. The company supports therapeutic pipeline development from hit identification to lead optimization by delivering comprehensive proteomics data. Its technology portfolio includes deep proteomic screening, global ubiquitinomics, high-throughput interactomics, and activity-based protein profiling to study targeted protein degradation and compound interactions. NEOsphere also offers neoVERSE, an AI-powered platform that automates the analysis and interpretation of large-scale proteomics data to support faster decision-making. The company’s workflows integrate cell culture, mass spectrometry, and advanced data analysis to provide end-to-end research solutions. Its platforms are designed to deliver precise, comprehensive, and high-throughput insights across a wide range of biological samples, including cell lines, primary cells, tissues, and patient-derived materials. Through these capabilities, NEOsphere Biotechnologies enables researchers to better characterize degraders, stabilizers, and other proximity-inducing molecules for therapeutic discovery.
Get involved at BioTechX Europe
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events